Clinical Trials Logo

New Daily Persistent Headache clinical trials

View clinical trials related to New Daily Persistent Headache.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05536050 Recruiting - Fibromyalgia Clinical Trials

Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Start date: July 28, 2022
Phase:
Study type: Observational

This research aims to look at the effect of low-dose naltrexone on the severity and frequency of attacks in people with chronic migraine with or without new daily persistent headache and fibromyalgia. A few studies suggest low-dose naltrexone is effective for fibromyalgia, but it has not been studied in patients with migraine and headaches. Our goal is to see if there is an improvement in either severity and frequency of attacks and overall impact on quality of life over a three-month period.